HK1203352A1 - Novel milk thistle extract, method for the production, and use - Google Patents

Novel milk thistle extract, method for the production, and use Download PDF

Info

Publication number
HK1203352A1
HK1203352A1 HK15103460.8A HK15103460A HK1203352A1 HK 1203352 A1 HK1203352 A1 HK 1203352A1 HK 15103460 A HK15103460 A HK 15103460A HK 1203352 A1 HK1203352 A1 HK 1203352A1
Authority
HK
Hong Kong
Prior art keywords
silybum marianum
extract
release rate
fruit extract
silymarin
Prior art date
Application number
HK15103460.8A
Other languages
English (en)
Chinese (zh)
Inventor
‧納戈爾
A‧纳戈尔
‧阿圭熱
J‧X‧阿圭热
‧普爾斯
S‧R‧普尔斯
Original Assignee
欧洲地中海股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 欧洲地中海股份有限公司 filed Critical 欧洲地中海股份有限公司
Publication of HK1203352A1 publication Critical patent/HK1203352A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK15103460.8A 2007-12-23 2011-01-26 Novel milk thistle extract, method for the production, and use HK1203352A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102007063115.6 2007-12-23
DE102007063115 2007-12-23
DE102008039271A DE102008039271A1 (de) 2007-12-23 2008-08-23 Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung
DE102008039271.5 2008-08-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK11100791.8A Addition HK1146896A (en) 2007-12-23 2008-12-23 Novel milk thistle extract, method for the production, and use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK11100791.8A Division HK1146896A (en) 2007-12-23 2008-12-23 Novel milk thistle extract, method for the production, and use

Publications (1)

Publication Number Publication Date
HK1203352A1 true HK1203352A1 (en) 2015-10-30

Family

ID=40690102

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103460.8A HK1203352A1 (en) 2007-12-23 2011-01-26 Novel milk thistle extract, method for the production, and use

Country Status (20)

Country Link
US (1) US20110027396A1 (cg-RX-API-DMAC10.html)
EP (2) EP2567703A3 (cg-RX-API-DMAC10.html)
JP (2) JP5442632B2 (cg-RX-API-DMAC10.html)
KR (2) KR101541938B1 (cg-RX-API-DMAC10.html)
CN (2) CN104189043A (cg-RX-API-DMAC10.html)
AU (1) AU2008340922B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0822069B8 (cg-RX-API-DMAC10.html)
CA (2) CA2709947C (cg-RX-API-DMAC10.html)
CY (1) CY1115081T1 (cg-RX-API-DMAC10.html)
DE (1) DE102008039271A1 (cg-RX-API-DMAC10.html)
DK (1) DK2222320T3 (cg-RX-API-DMAC10.html)
ES (1) ES2438003T3 (cg-RX-API-DMAC10.html)
HK (1) HK1203352A1 (cg-RX-API-DMAC10.html)
HR (1) HRP20131165T1 (cg-RX-API-DMAC10.html)
MX (1) MX2010006982A (cg-RX-API-DMAC10.html)
PL (1) PL2222320T3 (cg-RX-API-DMAC10.html)
PT (1) PT2222320E (cg-RX-API-DMAC10.html)
RU (1) RU2489161C2 (cg-RX-API-DMAC10.html)
SI (1) SI2222320T1 (cg-RX-API-DMAC10.html)
WO (1) WO2009080006A2 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8614341B2 (en) 2009-05-14 2013-12-24 Euromed S.A. Amorphous silibinin for the treatment of viral hepatitis
CN102225085B (zh) * 2011-06-20 2012-09-05 黑龙江大学 一种从水飞蓟秸秆中提取水飞蓟总黄酮的方法
KR101316806B1 (ko) * 2011-08-02 2013-10-10 (주)이뮤노텍 글루타치온과 실리마린을 유효성분으로 함유하는 항산화 및 간보호용 조성물
KR101655396B1 (ko) * 2013-08-06 2016-09-08 에스케이바이오랜드 주식회사 수용성 밀크씨슬 추출물 및 이의 제조방법
JP2015113332A (ja) * 2013-12-16 2015-06-22 花王株式会社 生薬粉体
CN104744447B (zh) * 2013-12-31 2017-12-26 天士力制药集团股份有限公司 水飞蓟宾迷迭香酸酯及其制备方法和用途
CN104651037A (zh) * 2014-01-17 2015-05-27 吴长军 一种亚临界流体萃取水飞蓟籽仁中油脂和蛋白的方法
CN105622594B (zh) * 2016-03-17 2019-05-17 江苏中兴药业有限公司 一种高纯度水飞蓟素的制备方法
ES2706008B8 (es) * 2017-09-22 2021-07-12 Euromed S A Procedimiento para la preparacion de una composicion a partir del cardo mariano y composicion obtenida
KR102242002B1 (ko) 2019-02-21 2021-04-19 주식회사 노바케이메드 동충하초균사체로 고상발효된 홍삼 추출물을 유효성분으로 함유하는 지방간 질환 예방 또는 치료용 조성물
CN111518090B (zh) * 2020-05-12 2021-08-10 沈阳药科大学 黄烷黄酮衍生物及其制备方法和用途
KR102669644B1 (ko) * 2023-06-27 2024-05-27 한국자연한방 주식회사 실리마린 생체이용률이 증대된 밀크씨슬 추출물을 포함하는 지방간 개선, 예방 또는 치료용 조성물
EP4775214A1 (en) * 2025-01-13 2026-07-15 Neilos S.r.l. Nutraceutical or pharmaceutical composition comprising an extract of silybum marianum for use in the treatment and/or prevention of hepato-biliary conditions or diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767666C3 (de) 1968-06-01 1986-07-31 Dr. Madaus & Co, 5000 Koeln Pharmazeutische Zubereitung gegen Lebererkrankungen
DE1923982C3 (de) 1969-05-10 1978-07-13 Hoechst Ag, 6000 Frankfurt Flammfestmachen von Polyurethanschaumstoffen
DE2020407A1 (de) 1970-04-27 1971-11-11 Bernhard Dr Janiak Technisches Verfahren zur Isolierung von Silimarin
FR2181188A5 (en) * 1972-04-20 1973-11-30 Dott Inverni Della Beffa Polyhydroxyphenylchromones - by solvent extn of non-defatted fruit of Silybum marianum
US4061765A (en) * 1973-01-19 1977-12-06 Dr. Madaus & Co. Polyhydroxyphenylchromanone salts and therapeutic composition
DD112261A1 (cg-RX-API-DMAC10.html) * 1974-06-18 1975-04-05
DE2914330A1 (de) * 1979-04-09 1980-10-30 Madaus & Co Dr Verfahren zur gewinnung von silymarin aus pflanzen
CH646695A5 (en) * 1980-10-06 1984-12-14 Madaus & Co Dr Method of obtaining silymarin from plants
DE3225688A1 (de) * 1982-07-09 1984-01-12 Suschnik Matthias Dr Verfahren zur gewinnung von silymarin aus silybum marianum
IT1241673B (it) 1989-10-09 1994-01-27 Istituto Biochimico Italiano Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
DE19501266A1 (de) 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
KR0161349B1 (ko) 1995-01-20 1998-11-16 무라따 야스따까 압전 자기 조성물
RU2102999C1 (ru) * 1996-07-10 1998-01-27 Куркин Владимир Александрович Способ получения экстракта расторопши пятнистой
DE19744459A1 (de) 1997-10-08 1999-04-15 Schwabe Willmar Gmbh & Co Flavonolignan-Zubereitungen, insbesondere Silymarin-Zubereitungen
IN192343B (cg-RX-API-DMAC10.html) * 2000-05-26 2004-04-10 Ranbaxy Lab Ltd
CZ292832B6 (cs) * 2001-08-30 2003-12-17 Ivax Pharmaceuticals S.R.O. Způsob přípravy silymarinu se zvýšenou rozpustností
JP2003135023A (ja) * 2001-10-30 2003-05-13 Os Kogyo Kk 健康食品
US7238373B2 (en) * 2003-04-04 2007-07-03 Nutritox Llc Nutritional supplement

Also Published As

Publication number Publication date
BRPI0822069B8 (pt) 2021-05-25
HRP20131165T1 (hr) 2014-01-03
JP5442632B2 (ja) 2014-03-12
JP2011507812A (ja) 2011-03-10
KR101541938B1 (ko) 2015-08-04
WO2009080006A2 (de) 2009-07-02
RU2489161C2 (ru) 2013-08-10
EP2567703A3 (de) 2013-03-20
JP2014074051A (ja) 2014-04-24
WO2009080006A3 (de) 2009-10-08
EP2567703A2 (de) 2013-03-13
DE102008039271A1 (de) 2009-06-25
AU2008340922B2 (en) 2012-07-19
BRPI0822069A2 (pt) 2015-06-23
CA2709947A1 (en) 2009-07-02
ES2438003T3 (es) 2014-01-15
SI2222320T1 (sl) 2014-01-31
US20110027396A1 (en) 2011-02-03
MX2010006982A (es) 2010-12-06
CA2922846A1 (en) 2009-07-02
RU2010130855A (ru) 2012-01-27
BRPI0822069B1 (pt) 2019-10-08
AU2008340922A1 (en) 2009-07-02
CN101925360A (zh) 2010-12-22
CA2709947C (en) 2016-05-17
EP2222320A2 (de) 2010-09-01
DK2222320T3 (da) 2013-12-16
KR20150038663A (ko) 2015-04-08
PT2222320E (pt) 2013-12-23
CY1115081T1 (el) 2016-12-14
EP2222320B1 (de) 2013-09-18
PL2222320T3 (pl) 2014-02-28
KR20100126272A (ko) 2010-12-01
CN104189043A (zh) 2014-12-10
KR101607445B1 (ko) 2016-03-29

Similar Documents

Publication Publication Date Title
AU2008340922B2 (en) Novel milk thistle extract, method for the production, and use
MX2008012065A (es) Extractos y metodos que comprenden especies de te verde.
US20190022159A1 (en) Novel method for preparing purified extracts of harpagophytum procumbens
KR101928767B1 (ko) 돌외로부터 분리된 신규한 지페노사이드 화합물
JP2006503102A (ja) 糖尿病の予防および治療のための天然化合物、その調製方法、およびその薬物的使用。
CN101168551A (zh) 马先蒿木脂素类化合物、制备方法及应用
JP4117029B2 (ja) ハルパゴフィタム プロカンベンス及び／又はハルパゴフィタム ゼイヘリ デンスから精製された抽出物、その製造方法及びその使用
HK1146896A (en) Novel milk thistle extract, method for the production, and use
KR101303541B1 (ko) 알코올성 간손상 내지 알코올성 지방간 예방 및 숙취해소 효과를 갖는 조성물
WO2006014499A1 (en) Cinnamon extract enriched for polyphenols and methods of preparing same
KR100733764B1 (ko) 합환피 추출물 또는 그로부터 분리한 쿠라리디놀을함유하는 고지혈증의 예방 및 치료용 조성물
KR20060082214A (ko) 항산화 활성을 갖는 신규 사가 크로마놀 유도체 화합물,이의 분리방법 및 이를 포함하는 항산제
EP0571520B1 (fr) Utilisation en therapeutique de pycnogenols pour la preparation de medicaments a activite anti-inflammatoire
NO309306B1 (no) Fremgangsmåte for oppnåelse av sammensetninger og/eller substanser med antineoplastisk aktivitet
CN111690023A (zh) 马钱苷乙酰化衍生物类环烯醚萜化合物及其提取方法和应用
JP2004256426A (ja) 抗腫瘍剤
Putri et al. Optimization Parameters of Natural Deep Eutectic Solvent Based on Choline Chloride and Fructose for Extraction of Polyphenol from Jotang (Spilanthes acmella) Stem
KR930004935B1 (ko) 항궤양 및 위산분비억제 효과를 가지는 약학적제제
KR20090100573A (ko) 산마늘 추출물을 함유하는 암 예방 또는 치료용 조성물
CA3067807A1 (en) Tongkat ali extract production processes and uses thereof
JP2004018395A (ja) 血圧降下剤、その製造方法及びプロポリス組成物